Testing effectiveness (Phase 2)Ended earlyNCT05415410What this trial is testingProof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD)Who this might be right forGVHD VectivBio AG 31
Testing effectiveness (Phase 2)Study completedNCT01700036What this trial is testingA Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host DiseaseWho this might be right forGraft vs Host Disease University of Michigan Rogel Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00492921What this trial is testingHigh-Dose Cyclophosphamide for Steroid Refractory GVHDWho this might be right forGraft Versus Host Disease Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 12
Not applicableApproved For MarketingNCT03147742What this trial is testingAn Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell TransplantWho this might be right forGraft-versus-host Disease (GVHD) Incyte Corporation
Testing effectiveness (Phase 2)Study completedNCT00388362What this trial is testingSirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host DiseaseWho this might be right forGraft vs Host Disease Stanford University 36
Testing effectiveness (Phase 2)UnknownNCT01158105What this trial is testingBortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD)Who this might be right forChronic Graft-versus-host Disease Baylor Research Institute 25
Early research (Phase 1)Looking for participantsNCT06991361What this trial is testingEx Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHDWho this might be right forGraft Versus Host Disease (cGvHD) Leslie Kean 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT06075706What this trial is testingTrial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host DiseaseWho this might be right forSteroid-refractory Acute Graft-versus-host Disease medac GmbH 49
Early research (Phase 1)Active Not RecruitingNCT04212416What this trial is testingLeflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host DiseaseWho this might be right forChronic Graft Versus Host DiseaseSteroid Refractory Graft Versus Host Disease City of Hope Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT00827398What this trial is testingTreatment of Steroid Resistant GVHD by Infusion MSCWho this might be right forGraft-versus-host-disease N.M. Wulffraat 50
Testing effectiveness (Phase 2)Looking for participantsNCT02918188What this trial is testingTherapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHDWho this might be right forChronic Graft-versus-host Disease Navy General Hospital, Beijing 21
Testing effectiveness (Phase 2)Study completedNCT03007238What this trial is testingExtracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host DiseaseWho this might be right forChronic Graft Versus Host Disease City of Hope Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT03459040What this trial is testingA Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHDWho this might be right forGraft-versus-host-diseaseGVHD John Levine 30
Very early researchStudy completedNCT04290429What this trial is testingTreatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD PatientsWho this might be right forGraft Versus Host Disease University of Freiburg 6
Testing effectiveness (Phase 2)Ended earlyNCT01530256What this trial is testingExploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)Who this might be right forAcute GvHD CSL Behring 3
Testing effectiveness (Phase 2)Study completedNCT00201786What this trial is testingPhase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host DiseaseWho this might be right forGraft-Versus-Host Disease Ohio State University Comprehensive Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT00408928What this trial is testingStudy on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host DiseaseWho this might be right forGraft-versus-Host Disease Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 11
Testing effectiveness (Phase 2)Ended earlyNCT00032773What this trial is testingDose-finding Study Using Pentostatin for Injection in the Treatment of Steroid-refractory aGvHDWho this might be right forAcute Graft Versus Host Disease Astex Pharmaceuticals, Inc. 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06677255What this trial is testingA Phase I/II Trial of VUM02 Injection for Steroid-refractory Acute Graft-versus-host Disease (SR-aGvHD) TreatmentWho this might be right forSteroid-refractory Acute Graft-versus-host Disease Wuhan Optics Valley Vcanbiopharma Co., Ltd. 149
Not applicableNo Longer AvailableNCT03172455What this trial is testingEarly Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)Who this might be right forAcute-graft-versus-host DiseaseSteroid Refractory Acute Graft Versus Host DiseaseGraft-versus-host-disease+5 more Impatients N.V. trading as myTomorrows